Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Inovio Pharmaceuticals (NASDAQ:INO) Stock Retreats: What Could Turn It Around?

● Inovio Pharmaceuticals is approaching one of the most consequential moments in its long history, with a key regulatory decision on its lead DNA medicine drawing near.

Nitish Kishor | 10 September 2026

Top Healthcare Stock Watch: What Could Drive Insmed (NASDAQ:INSM) Next?

● Insmed has transformed itself from a one-product rare-disease company into one of the most closely followed names in mid-to-large-cap biopharma.

Nitish Kishor | 10 September 2026

Inspire Medical Systems, Inc (NYSE:INSP) Jumps: Why It Is Suddenly on Investors' Radar

● The advance coincided with Inspire's scheduled presentation at the Wells Fargo 21st Annual Healthcare Conference on 9 September, where management reiterated an outlook for sequentialRevenuegrowth in the second half and emphasised newer closed-loop technology and clearer reimbursement coding.

Nitish Kishor | 10 September 2026

Intensity Therapeutics (NASDAQ:INTS) Drifts Lower: Is the Pullback Creating a New Setup?

● Based in Westport, Connecticut, Intensity Therapeutics is a clinical-stage biotechnology company developing intratumoral cancer therapies designed to kill tumours locally while triggering a systemic anti-tumour immune response.

Nitish Kishor | 10 September 2026

The Company Behind OTC:IGRW Is Named Interactive Health Network. It Sells Incense.

The ticker IGRW (OTC:IGRW) is attached to a corporate name, Interactive Health Network, that hints at digital health or medical services. TheBusinessbehind the symbol is far more ordinary: it operates as House of Mohan, a distributor of incense, with shares changing hands at essentially …

Nitish Kishor | 10 September 2026

ImageneBio (NASDAQ: IMA) Stock Eases Back: Key Levels and Catalysts to Watch

ImageneBio, Inc. (NASDAQ: IMA) has quietly become one of the more intriguing names in inflammatory-disease drug development, backed by a well-capitalizedBalance Sheetand a lead antibody aimed at large dermatology markets. The stock, trading onNasdaqunder IMA, slipped modestly in recent action, but that small wobble …

Nitish Kishor | 10 September 2026

IMV (OTC:IMVIF) Stock: What Remains After Its Delisting and Asset Sale to BioVaxys

The story behind ticker IMV (OTC:IMVIF)IF is less an active market opportunity than a cautionary corporate epilogue. IMV Inc., once a Nova Scotia-based clinical-stage immuno-oncology company, is no longer an operating business.

Nitish Kishor | 10 September 2026

Integrated BioPharma, Inc (OTC:INBP) Goes Quiet: Why It Could Still Be One to Watch in September 2026

● Founded in 1980 and based in New Jersey, Integrated BioPharma manufactures and distributes vitamins, nutritional supplements and herbal products, largely through contractManufacturingfor distributors, marketers and healthcare providers.

Nitish Kishor | 10 September 2026

Infinity Pharmaceuticals' (OTC:INFIQ) Cancer Ambitions Ended When a Merger Fell Apart in 2023

Infinity Pharmaceuticals, Inc (OTC:INFIQ) once carried real ambition in cancer immunotherapy, and for years its shares traded actively onNasdaqunder INFI. Today the story reads very differently. The ticker now appears as INFIQ, the letter markets attach to companies in bankruptcy, and the stock changes …

Nitish Kishor | 10 September 2026

Radnostix, Inc (OTC:INIS) Shares Rally: Is It Building Fresh Momentum in September 2026?

● 6% single-session rally, but on a stock priced around a nickel that equates to a fraction of a cent, and no confirmed catalyst explains that specific move.

Nitish Kishor | 10 September 2026
Support

Hi! How can we help you today?

Loading…